NCT06204289

Brief Summary

Lung cancer is the leading cause of cancer-related deaths worldwide, with a mortality rate of 18%. The prognosis of lung cancer is progressive and devastating, which may cause patients to experience problems during the treatment and care process. Due to the problems experienced by lung cancer patients, their need for support increases and the care process is provided mostly in the home environment, causing family members to take on important roles as caregivers. Therefore, the resilience of family caregivers decreases and they feel burden.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 31, 2023

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

January 3, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

January 12, 2024

Completed
10 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 22, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 29, 2024

Completed
Last Updated

August 6, 2024

Status Verified

August 1, 2024

Enrollment Period

6 months

First QC Date

January 3, 2024

Last Update Submit

August 5, 2024

Conditions

Keywords

Lung cancerFamily caregiversCaregiver burdenResilience

Outcome Measures

Primary Outcomes (1)

  • Zarit Burden Interview (ZBI)

    The ZBI is a measure of caregiving burden developed by Zarit et al. (1980). The Turkish version of this scale has been validated by Inci and Erdem (2018). It consists of 22 items, and responses are recorded on a five-point Likert scale. The level of caregiver burden can be ascertained based on the total scale scores, which range from 0 to 88. Higher scores indicate a higher level of caregiver burden.The Cronbach's α of the Turkish version of this scale was 0.91 in Inci and Erdem (2018) validation study.

    The scale was filled in the baseline (before the beginning of the nurse-led supportive care), 8th and 12th weeks.

Secondary Outcomes (1)

  • Connor-Davidson Resilience Scale Short Form (CDRSSF)

    The scale was filled in the baseline (before the beginning of the nurse-led supportive care), 8th and 12th weeks.

Study Arms (2)

Nurse-led Supportive Care Group

EXPERIMENTAL

Nurse-led supportive care was given to family caregivers of patients with lung cancer.

Behavioral: Nurse-led Supportive Care Programme

Control Group

NO INTERVENTION

The control group received only usual care. They did not receive any intervention during the study period.

Interventions

Nurse-led supportive care programme was applied to family caregivers for eight weeks in the form of face-to-face clinic interviews. It took an average of 40 minutes to interview with family caregivers at the clinic.

Nurse-led Supportive Care Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • A family member who has been a primary caregiver for at least one year
  • Literate
  • Willingness to participate in the study

You may not qualify if:

  • Have any communication disability
  • Have any diagnosed physical or psychological disorder
  • Receiving any supportive care

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Izmir Bakircay University Faculty of Health Sciences

Izmir, 35560, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Lung NeoplasmsCaregiver Burden

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract DiseasesStress, PsychologicalBehavioral SymptomsBehavior

Study Officials

  • Pinar Zorba Bahceli, PhD

    Izmir Bakircay University Faculty of Health Sciences Izmir, Turkey, 35560

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

January 3, 2024

First Posted

January 12, 2024

Study Start

July 31, 2023

Primary Completion

January 22, 2024

Study Completion

February 29, 2024

Last Updated

August 6, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations